Victory Capital Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-13,810
| Closed | -$28K | – | 2537 |
|
2023
Q3 | $28K | Buy |
13,810
+815
| +6% | +$1.65K | ﹤0.01% | 2428 |
|
2023
Q2 | $29.9K | Sell |
12,995
-302
| -2% | -$695 | ﹤0.01% | 2426 |
|
2023
Q1 | $40.3K | Buy |
+13,297
| New | +$40.3K | ﹤0.01% | 2462 |
|
2018
Q4 | – | Sell |
-151,060
| Closed | -$1.43M | – | 1778 |
|
2018
Q3 | $1.43M | Sell |
151,060
-7,660
| -5% | -$72.4K | ﹤0.01% | 1184 |
|
2018
Q2 | $1.16M | Sell |
158,720
-8,430
| -5% | -$61.6K | ﹤0.01% | 1218 |
|
2018
Q1 | $836K | Buy |
167,150
+16,430
| +11% | +$82.2K | ﹤0.01% | 1274 |
|
2017
Q4 | $761K | Buy |
150,720
+21,460
| +17% | +$108K | ﹤0.01% | 1273 |
|
2017
Q3 | $801K | Sell |
129,260
-3,550
| -3% | -$22K | ﹤0.01% | 1259 |
|
2017
Q2 | $478K | Buy |
+132,810
| New | +$478K | ﹤0.01% | 1319 |
|